HBI Deals+Insights / News
The US-based med tech giant GE HealthCare is investing $138 million to expand its contrast media manufacturing site in Cork.
Iodinated contrast media (ICM) are injectable diagnostic agents which enhance the visibility of organs, blood vessels, and tissues during X-rays and CT scans, playing a key role in diagnosing conditions like cancer and heart disease.





